BioPharma Dive - Latest News

Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK

The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority review on a key drug and Third Harmonic restructured.

Feb 11, 2025 - 17:54
 0
Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK

The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority review on a key drug and Third Harmonic restructured.

Read More

Tags:

Previous Article

Annoying Extended Warranty Pop-Up Ad Takes Over Jeep Owner's Infotainment Screen

Next Article

Hain Celestial eyeing GLP-1 opportunities

Related Posts

Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair

Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’...

Feb 21, 2025  0

New study offers hints of GLP-1 drugs’ potential in curbing alcohol cravings

New study offers hints of GLP-1 drugs’ potential in cur...

Feb 12, 2025  0

Sanofi to take $250M charge on study failure for E. Coli vaccine

Sanofi to take $250M charge on study failure for E. Col...

Feb 13, 2025  0